FFAR2 and hepatocellular carcinoma: Activation of GPR43 suppresses the interleukin 6/Janus kinase 1/signal transducer and activator of transcription 3 signaling pathway, thereby impeding progression of MASLD-associated HCC (38) (Figure 1C).